Oregon pauses a proposed psilocybin fee increase, California earmarks $4.7M for psychedelic research, and the DEA moves to schedule five tryptamines—here’s why it matters.
DEA issued a scheduling order for five tryptamines as FDA momentum grows, including breakthrough status for a 4‑OH‑DiPT drug candidate aimed at postpartum depression.
Wan't to get Cannabis News and Blog Updates from Bud Lords Weed Delivery in Washington DC? Sign up and Become a member to get updates on new blogs and washington dc weed events.